Elevated eosinophil level predicted long time to next treatment in relapsed or refractory myeloma patients treated with lenalidomide

Lenalidomide is an immunomodulatory drug that is administered commonly in patients with relapsed or refractory multiple myeloma (RRMM). Eosinophils have immunological functions, for instance, in allergic diseases and asthma. The purpose of this study was to investigate the clinical significance of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Kazuhito, Nishiwaki, Kaichi, Gunji, Tadahiro, Katori, Mitsuji, Masuoka, Hidekazu, Yano, Shingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050101/
https://www.ncbi.nlm.nih.gov/pubmed/31950647
http://dx.doi.org/10.1002/cam4.2828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050101/
https://www.ncbi.nlm.nih.gov/pubmed/31950647
http://dx.doi.org/10.1002/cam4.2828

Ejemplares similares